Department of General Surgery, Peking Union Medical College Hospital, CAMS and PUMC, No. 1 Shuai Fu Yuan, Dongcheng District, Beijing 100730, China,
Front Biosci (Landmark Ed). 2015 Jun 1;20(6):919-26. doi: 10.2741/4346.
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. It arises in the stomach, small intestine, colon, rectum and esophagus. KIT gene mutation is a feature of GIST, in addition to PDGFRA gene mutation. KIT gene mutations have been observed to be involved in the development of GIST, its recurrence after surgery and chemotherapy resistance in GIST. Exons 13, 17, 9, and mainly exon 11 are concerned in these biological behaviors of GIST. In this review, we will discuss on the involvement of KIT gene mutations in the tumorigenesis, recurrence and chemotherapeutic resistance of GIST.
胃肠道间质瘤(GIST)是胃肠道最常见的间叶源性肿瘤。它发生于胃、小肠、结肠、直肠和食管。KIT 基因突变是 GIST 的一个特征,除了 PDGFRA 基因突变。KIT 基因突变被观察到参与 GIST 的发生、手术后复发和 GIST 化疗耐药。在这些 GIST 的生物学行为中,涉及外显子 13、17、9,主要是外显子 11。在这篇综述中,我们将讨论 KIT 基因突变在 GIST 的肿瘤发生、复发和化疗耐药中的作用。